We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-8.37%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.28B
AUM Growth
-$1.41B
Cap. Flow
-$1.19B
Cap. Flow %
-22.61%
Top 10 Hldgs %
53.54%
Holding
466
New
23
Increased
24
Reduced
24
Closed
360

Top Buys

Rank Stock Value
1
NAMS icon
NewAmsterdam Pharma
NAMS
+$72.5M
2
LEGN icon
Legend Biotech
LEGN
+$64.3M
3
OSCR icon
Oscar Health
OSCR
+$64.1M
4
DVAX
Dynavax Technologies
DVAX
+$62.6M
5
INDV icon
Indivior Pharmaceuticals
INDV
+$39M

Top Sells

Rank Stock Value
1
NUVL
Nuvalent
NUVL
+$187M
2
KURA icon
Kura Oncology
KURA
+$106M
3
CPRX
Catalyst Pharmaceutical
CPRX
+$66.5M
4
SGRY icon
Surgery Partners
SGRY
+$57.4M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$56.2M

Sector Composition

Rank Sector Weight
1 Healthcare 87.97%
2 Industrials 0.23%
3 Consumer Staples 0.01%
4 Energy 0%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BSY icon
151
Bentley Systems
BSY
$10.2B
– –
-10,588
Closed -$538K
BVS icon
152
Bioventus
BVS
$843M
– –
-62,917
Closed -$752K
BYRN icon
153
Byrna Technologies
BYRN
$93.7M
– –
-85,037
Closed -$1.44M
CACI icon
154
CACI
CACI
$11B
– –
-512
Closed -$258K
CAH icon
155
Cardinal Health
CAH
$53.7B
– –
-7,849
Closed -$867K
CALM icon
156
Cal-Maine
CALM
$4.2B
– –
-4,968
Closed -$372K
CCRN
157
DELISTED
Cross Country Healthcare
CCRN
– –
-17,125
Closed -$230K
CDNA icon
158
CareDx
CDNA
$1.88B
– –
-30,871
Closed -$964K
CENT icon
159
Central Garden & Pet Co
CENT
$2.71B
– –
-53,827
Closed -$1.96M
CEVA icon
160
CEVA Inc
CEVA
$980M
– –
-11,915
Closed -$288K
CFFN icon
161
Capitol Federal Financial
CFFN
$1.07B
– –
-13,165
Closed -$76.9K
CFG icon
162
Citizens Financial Group
CFG
$30.1B
– –
-21,678
Closed -$890K
CG icon
163
Carlyle Group
CG
$16.7B
– –
-15,332
Closed -$660K
CGBD icon
164
Carlyle Secured Lending
CGBD
$710M
– –
-23,006
Closed -$390K
CHGG icon
165
Chegg
CHGG
$110M
– –
-85,244
Closed -$151K
CI icon
166
Cigna
CI
$77B
– –
-1,260
Closed -$437K
CIVI
167
DELISTED
Civitas Resources
CIVI
– –
-8,805
Closed -$446K
CMS icon
168
CMS Energy
CMS
$22.9B
– –
-3,297
Closed -$233K
CNDT icon
169
Conduent
CNDT
$234M
– –
-75,446
Closed -$304K
CNX icon
170
CNX Resources
CNX
$4.77B
– –
-9,972
Closed -$325K
CNXC icon
171
Concentrix
CNXC
$1.5B
– –
-20,438
Closed -$1.05M
CODI icon
172
Compass Diversified
CODI
$755M
– –
-16,537
Closed -$366K
COF icon
173
Capital One
COF
$127B
– –
-6,291
Closed -$942K
COLL icon
174
Collegium Pharmaceutical
COLL
$1.15B
– –
-31,696
Closed -$1.22M
COO icon
175
Cooper Companies
COO
$13.7B
– –
-3,716
Closed -$410K
5 6
7
8 9

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q4 2024 Portfolio in Review

As of Q4 2024, Deerfield Management held 466 positions worth $5.28B, down 21% from $6.69B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Deerfield Management withdrew a net $1.19B in Q4 2024, closing 360 positions and reducing 24 holdings. Its most notable exit was Kura Oncology, an estimated $106M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 87% a quarter earlier, followed by Industrials and Consumer Staples.

Against the trend, Deerfield Management opened a new position in Legend Biotech worth $50.5M.

  • Deerfield Management's largest Q4 2024 buy was Legend Biotech: 1,551,718 shares worth $50.5M.
  • Deerfield Management added most to NewAmsterdam Pharma in Q4 2024, an estimated $72.5M increase.
  • Deerfield Management's biggest Q4 2024 reduction was Nuvalent, cutting an estimated $187M.
  • Deerfield Management fully exited Kura Oncology in Q4 2024, selling an estimated $106M.
  • Deerfield Management's ten largest holdings make up 54% of its $5.28B portfolio in Q4 2024.
  • Deerfield Management opened 23 new positions and closed 360 in Q4 2024.
  • Deerfield Management's portfolio value fell 21% quarter-over-quarter to $5.28B.

Based on Deerfield Management's 13F filing for Q4 2024, filed 14 Feb 2025.